Law360, New York (April 19, 2011, 8:11 PM ET) -- The former CEO of InterMune Inc., convicted of fraudulently marketing the drug Actimmune to treat a deadly lung disease, was denied a new trial Monday after a California federal judge ruled that previously undisclosed documents didn't prejudice the case against him.
Dr. W. Scott Harkonen, who was sentenced April 13 to a six-month term of home confinement, had argued for a new trial because prosecutors did not disclose 67 pages of documents from the U.S. Department of Veterans Affairs that allegedly proved an August 2002 InterMune...
No New Trial For Former InterMune CEO
To view the full article, take a free trial now.
